Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients. 2009

E Langesaeter, and L A Rosseland, and A Stubhaug
Division of Anaesthesia and Intensive Care, Oslo University Hospital-Rikshospitalet, N-0027 Oslo, Norway. eldrid.langesaeter@rikshospitalet.no

BACKGROUND The haemodynamic effects of oxytocin 5 u have been described previously, but still some authors attribute these effects to the delivery itself. We studied the haemodynamic effects of two repeated doses of oxytocin i.v. in 20 healthy women during spinal anaesthesia for Caesarean delivery. METHODS Data were obtained from a randomized controlled study of 80 pregnant women undergoing an elective Caesarean section. All women had an arterial line inserted, and LidCOPlus was used for measuring cardiac output (CO), stroke volume (SV), and systemic vascular resistance (SVR). RESULTS Twenty women required a second bolus of oxytocin 5 u. Both the first and the second doses produced clinically and statistically significant haemodynamic changes, but the haemodynamic changes induced by the second dose were smaller than after the first dose. The mean maximal change in CO after the first and second doses were 94% (CI 70-117) and 42% (CI 33-52), respectively (P<0.0001), and for systolic arterial pressure 31% (CI 27-35) and 23% (CI 20-27), respectively (P=0.003). CONCLUSIONS An initial bolus of oxytocin 5 u produced prominent haemodynamic changes, whereas a second bolus produced smaller changes. This could be due to desensitization of endothelial oxytocin receptors.

UI MeSH Term Description Entries
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D010121 Oxytocin A nonapeptide hormone released from the neurohypophysis (PITUITARY GLAND, POSTERIOR). It differs from VASOPRESSIN by two amino acids at residues 3 and 8. Oxytocin acts on SMOOTH MUSCLE CELLS, such as causing UTERINE CONTRACTIONS and MILK EJECTION. Ocytocin,Pitocin,Syntocinon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002585 Cesarean Section Extraction of the FETUS by means of abdominal HYSTEROTOMY. Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Langesaeter, and L A Rosseland, and A Stubhaug
January 1994, International journal of obstetric anesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
July 2002, International journal of obstetric anesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
May 2017, International journal of obstetric anesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
September 2007, Anaesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
October 2011, BJOG : an international journal of obstetrics and gynaecology,
E Langesaeter, and L A Rosseland, and A Stubhaug
July 2010, British journal of anaesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
July 2010, British journal of anaesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
March 2010, British journal of anaesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
June 2010, British journal of anaesthesia,
E Langesaeter, and L A Rosseland, and A Stubhaug
July 2013, International journal of obstetric anesthesia,
Copied contents to your clipboard!